FDA Reverses Trump Era Limits On Abortion Pill Access During Pandemic

Letting patients access mifepristone through telemedicine does not appear to pose any safety risks, the acting FDA commissioner said.Letting patients access mifepristone through telemedicine does not appear to pose any safety risks, the acting FDA commissioner said.Read More